Importantly, melanoma cells do not express IGF-138, and there was no significant difference in proliferation in control treated cells (Fig. 5f), suggesting that differential GCNT2/I-branched glycan expression can modulate melanoma cell proliferation in an IGF-1-mediated manner. The gene discussed is GCNT2; the disease is melanoma.